Insider transactions

EDGAR

Nkarta, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
3 transactions, 33,471 shares
Sum of shares × price per share: 70,421.61

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–17 of 17

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-06-18 Filed 2026-06-22HASTINGS PAUL J Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,7762.71
4,812.96

Derived: shares × price per share. Exact value 4812.96.

390,247Direct (D) No
F1, F2
  • F1 Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
  • F2 Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on May 31, 2026.
Open filing 0001193125-26-277507 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11RA CAPITAL MANAGEMENT, L.P. Director · 10% ownerRA Capital Healthcare Fund LP Director · 10% ownerRA Capital Nexus Fund, L.P. DirectorKolchinsky Peter Director · 10% ownerShah Rajeev M. Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Indirect (I) See FootnotesNo
F1, F2, F3
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award, subject to Dr. Scheiner's continued service through the applicable vesting date. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Dr. Scheiner's separation from service with the Issuer due to the his death or disability (as described in the applicable award agreement).
  • F2 RA Capital Management, L.P. (the Adviser) is the investment manager for RA Capital Healthcare Fund, L.P. (the Fund) and RA Capital Nexus Fund, L.P. (the Nexus Fund). The general partner of the Adviser is RA Capital Management GP, LLC (the Adviser GP), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
  • F3 Under Dr. Scheiner's arrangement with the Adviser, Dr. Scheiner holds the option for the benefit of the Fund and the Nexus Fund. Dr. Scheiner is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock.
Open filing 0001231919-26-000621 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Vratsanos George Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Direct (D) No
F1
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or disability (as described in the applicable award agreement).
Open filing 0001193125-26-267538 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11George Simeon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Direct (D) No
F1
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or disability (as described in the applicable award agreement).
Open filing 0001193125-26-267601 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Dybbs Michael Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Direct (D) No
F1
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or disability (as described in the applicable award agreement).
Open filing 0001193125-26-267519 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Behbahani Ali Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Direct (D) No
F1
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or disability (as described in the applicable award agreement).
Open filing 0001193125-26-267632 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11PATTERSON LEONE D Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Direct (D) No
F1
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or disability (as described in the applicable award agreement).
Open filing 0001193125-26-267521 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Scheiner Zachary Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Direct (D) No
F1, F2
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or disability (as described in the applicable award agreement).
  • F2 Under the Reporting Person's arrangement with RA Capital Management, L.P. (the Adviser), the Reporting Person holds the stock option for the benefit of the RA Capital Healthcare Fund, L.P. (the Fund) and the RA Capital Nexus Fund, L.P. (the Nexus Fund). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund and the Nexus Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying common stock.
Open filing 0001193125-26-267524 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-11Thedinga Angela Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (37,000) — exercise price 2.46
Acquired (A)37,0000—37,000Direct (D) No
F1
  • F1 All shares subject to the option vest 100% on the first to occur of (i) June 10, 2027 or (ii) the day immediately preceding the first annual meeting of the Issuer's stockholders to occur after the date of grant of the award. Each grant, to the extent outstanding and otherwise unvested, will become fully vested should a change in control of the Issuer occur (as described in the applicable award agreement) or upon the Reporting Person's separation from service with the Issuer due to the Reporting Person's death or disability (as described in the applicable award agreement).
Open filing 0001193125-26-267517 Read from the filing’s XML Dispute this row
2026-01-15 Filed 2026-01-20HASTINGS PAUL J Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)26,0462.07
53,915.22

Derived: shares × price per share. Exact value 53915.22.

390,023Direct (D) No
F1
  • F1 Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
Open filing 0001193125-26-016865 Read from the filing’s XML Dispute this row
2026-01-15 Filed 2026-01-20Mahmood Nadir Officer: President
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,6492.07
11,693.43

Derived: shares × price per share. Exact value 11693.43.

167,727Direct (D) No
F1
  • F1 Represents shares sold to satisfy tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units and does not represent a discretionary transaction by the Reporting Person.
Open filing 0001193125-26-016862 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-08Mahmood Nadir Officer: President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)80,0000—173,376Direct (D) No
F1
  • F1 Represents Restricted Stock Units (RSUs) which vest in four equal annual installments beginning on January 14, 2027. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Open filing 0001193125-26-007897 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-08Mahmood Nadir Officer: President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (160,000) — exercise price 1.93
Acquired (A)160,0000—160,000Direct (D) No
F2
  • F2 This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2026.
Open filing 0001193125-26-007897 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-08HASTINGS PAUL J Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)94,0000—416,069Direct (D) No
F1, F2
  • F1 Represents Restricted Stock Units (RSUs) which vest in four equal annual installments beginning on January 14, 2027. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
  • F2 Includes 2,000 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on November 30, 2025.
Open filing 0001193125-26-007896 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-08HASTINGS PAUL J Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (562,000) — exercise price 1.93
Acquired (A)562,0000—562,000Direct (D) No
F3
  • F3 This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2026.
Open filing 0001193125-26-007896 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-08Rose Shawn Marshall Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)70,0000—70,000Direct (D) No
F1
  • F1 Represents Restricted Stock Units (RSUs) which vest in four equal annual installments beginning on January 14, 2027. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
Open filing 0001193125-26-007898 Read from the filing’s XML Dispute this row
2026-01-06 Filed 2026-01-08Rose Shawn Marshall Officer: See Remarks
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (right to buy) — underlying Common Stock (139,000) — exercise price 1.93
Acquired (A)139,0000—139,000Direct (D) No
F2
  • F2 This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2026.
Open filing 0001193125-26-007898 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 129

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
RA CAPITAL MANAGEMENT, L.P. 10,805,129 SH28,309,438 dollarsUnchanged Prior quarter: 10,805,129Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager6,847,208 SH17,939,685 dollarsHigher by 546,996 Prior quarter: 6,300,212Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
NEA Management Company, LLC 3,568,781 SH9,350,206 dollarsUnchanged Prior quarter: 3,568,781Open filing 0001072613-26-000901 Filed 2026-11-16 Dispute this row
SAMSARA BIOCAPITAL, LLC 3,507,666 SH9,190,085 dollarsUnchanged Prior quarter: 3,507,666Open filing 0001744967-26-000014 Filed 2026-11-16 Dispute this row
SR ONE CAPITAL MANAGEMENT, LP 3,333,333 SH8,733,333 dollarsUnchanged Prior quarter: 3,333,333Open filing 0001012975-26-001062 Filed 2026-11-16 Dispute this row
GSK plc 3,150,732 SH8,254,918 dollarsUnchanged Prior quarter: 3,150,732Open filing 0001999371-26-024635 Filed 2026-11-05 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 2,363,401 SH6,192,111 dollarsHigher by 136,986 Prior quarter: 2,226,415Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
Monaco Asset Management SAM Partly reported under another manager2,185,666 SH5,726,445 dollarsLower by 187,734 Prior quarter: 2,373,400Open filing 0001803593-26-000014 Filed 2026-11-09 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager1,728,750 SH4,524 dollarsHigher by 368,202 Prior quarter: 1,360,548Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager1,698,565 SH4,450,240 dollarsLower by 476,180 Prior quarter: 2,174,745Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
TWO SIGMA INVESTMENTS, LP 1,687,812 SH4,422,067 dollarsLower by 185,481 Prior quarter: 1,873,293Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
WASATCH ADVISORS LP Partly reported under another manager1,666,596 SH4,366,482 dollarsHigher by 88,749 Prior quarter: 1,577,847Open filing 0000814133-26-000137 Filed 2026-10-13 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager1,400,319 SH3,668,837 dollarsHigher by 346,068 Prior quarter: 1,054,251Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager1,320,927 SH3,460,829 dollarsHigher by 34,818 Prior quarter: 1,286,109Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,313,651 SH3,442,476 dollarsHigher by 28,144 Prior quarter: 1,285,507Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Alyeska Investment Group, L.P. 984,840 SH2,580,281 dollarsHigher by 500,000 Prior quarter: 484,840Open filing 0001172661-26-005329 Filed 2026-11-16 Dispute this row
AWM Investment Company, Inc. 906,000 SH2,373,720 dollarsUnchanged Prior quarter: 906,000Open filing 0001535264-26-000061 Filed 2026-11-13 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager799,319 SH2,094,216 dollarsLower by 378,333 Prior quarter: 1,177,652Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Blackstone Inc. Partly reported under another manager747,044 SH1,957,255 dollarsUnchanged Prior quarter: 747,044Open filing 0001193125-26-463513 Filed 2026-11-16 Dispute this row
PANAGORA ASSET MANAGEMENT INC 663,497 SH1,738,362 dollarsHigher by 80,248 Prior quarter: 583,249Open filing 0000883677-26-000011 Filed 2026-11-12 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager612,058 SH1,603,593 dollarsLower by 60,952 Prior quarter: 673,010Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager557,792 SH1,461,415 dollarsLower by 5,188 Prior quarter: 562,980Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Peapod Lane Capital LLC 518,406 SH1,358,224 dollarsLower by 31,517 Prior quarter: 549,923Open filing 0001941040-26-000768 Filed 2026-10-22 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager510,615 SH1,337,811 dollarsHigher by 27,404 Prior quarter: 483,211Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager382,828 SH1,003,009 dollarsHigher by 11,403 Prior quarter: 371,425Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 382,478 SH1,002,092 dollarsHigher by 34,292 Prior quarter: 348,186Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager349,922 SH916,797 dollarsHigher by 86,149 Prior quarter: 263,773Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager347,554 SH910,592 dollarsLower by 86,428 Prior quarter: 433,982Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 303,642 SH795,542 dollarsHigher by 1,726 Prior quarter: 301,916Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager237,853 SH623,175 dollarsHigher by 75,344 Prior quarter: 162,509Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
XTX Topco Ltd Partly reported under another manager232,024 SH607,903 dollarsLower by 57,961 Prior quarter: 289,985Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 214,761 SH562,674 dollarsLower by 108,898 Prior quarter: 323,659Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
Invesco Ltd. Partly reported under another manager204,543 SH535,903 dollarsLower by 2,772 Prior quarter: 207,315Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Qube Research Technologies Ltd 194,977 SH510,840 dollarsHigher by 74,168 Prior quarter: 120,809Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Man Group plc Partly reported under another manager149,259 SH391,059 dollarsHigher by 49,212 Prior quarter: 100,047Open filing 0001637460-26-000004 Filed 2026-11-16 Dispute this row
FMR LLC Partly reported under another manager144,824 SH379,438 dollarsHigher by 14,882 Prior quarter: 129,942Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
LOS ANGELES CAPITAL MANAGEMENT LLC 142,653 SH373,751 dollarsHigher by 101,785 Prior quarter: 40,868Open filing 0001177206-26-000010 Filed 2026-11-12 Dispute this row
NANO CAP NEW MILLENNIUM GROWTH FUND L P Partly reported under another manager140,000 SH366,800 dollarsHigher by 10,000 Prior quarter: 130,000Open filing 0001277890-26-000005 Filed 2026-11-13 Dispute this row
Point72 Asset Management, L.P. 137,054 SH359,081 dollarsHigher by 30,248 Prior quarter: 106,806Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 132,768 SH347,852 dollarsHigher by 1,793 Prior quarter: 130,975Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager132,218 SH346,411 dollarsHigher by 10,648 Prior quarter: 121,570Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
GSA CAPITAL PARTNERS LLP 127,761 SH335 dollarsHigher by 14,359 Prior quarter: 113,402Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager124,689 SH326,685 dollarsLower by 344,866 Prior quarter: 469,555Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
BRIDGEWAY CAPITAL MANAGEMENT, LLC 120,965 SH316,928 dollarsLower by 1,835 Prior quarter: 122,800Open filing 0001107261-26-000007 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager117,797 SH308,628 dollarsHigher by 2,964 Prior quarter: 114,833Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
Empowered Funds, LLC Partly reported under another manager108,165 SH283,392 dollarsHigher by 38,523 Prior quarter: 69,642Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager100,950 SH264,489 dollarsUnchanged Prior quarter: 100,950Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Susquehanna Portfolio Strategies, LLC 95,253 SH249,563 dollarsLower by 31,086 Prior quarter: 126,339Open filing 0001996449-26-000009 Filed 2026-11-16 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager94,851 SH248,510 dollarsUnchanged Prior quarter: 94,851Open filing 0000748054-26-000008 Filed 2026-11-12 Dispute this row
WINTON GROUP Ltd 91,098 SH238,677 dollarsHigher by 75,298 Prior quarter: 15,800Open filing 0001612063-26-000014 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • T. Rowe Price Investment Management, Inc. 455,033 SH
  • Sixth Street Partners Management Company, L.P. 130,975 SH
  • MACKENZIE FINANCIAL CORP 115,189 SH
  • JACOBS LEVY EQUITY MANAGEMENT, INC 82,658 SH
  • Marquette Asset Management, LLC 75,071 SH
  • Verdad Advisers, LP 51,503 SH
  • Graham Capital Management, L.P. 23,978 SH
  • Creative Planning 21,990 SH
  • JANE STREET GROUP, LLC 20,000 SH
  • CAPTRUST FINANCIAL ADVISORS 18,515 SH
  • Merit Financial Group, LLC 15,703 SH
  • BRIGHTON JONES LLC 14,751 SH
  • Focus Partners Wealth 12,940 SH
  • INTECH INVESTMENT MANAGEMENT LLC 12,478 SH
  • Spark Investment Management LLC 11,700 SH
  • Quadrature Capital Ltd 11,508 SH
  • Pallas Capital Advisors LLC 10,851 SH
  • Integrated Wealth Concepts LLC 2,464 SH
  • Curated Wealth Partners LLC 1,754 SH
  • MARK SHEPTOFF FINANCIAL PLANNING, LLC 200 SH
  • Basecamp Wealth Advisors LLC 24 SH
  • Wealth Enhancement Trust Services, Inc. 19 SH
  • JPL Wealth Management, LLC 9 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
New Enterprise Associates 15, L.P. Common Stock, $0.0001 par value per share4.93,568,781.0005/19/2026 Filed 2026-05-19SCHEDULE 13D/AAmendment 3Open filing 0001072613-26-000486 Dispute this row
NEA Partners 15, L.P. Common Stock, $0.0001 par value per share4.93,568,781.0005/19/2026 Filed 2026-05-19SCHEDULE 13D/AAmendment 3Open filing 0001072613-26-000486 Dispute this row
NEA 15 GP, LLC Common Stock, $0.0001 par value per share4.93,568,781.0005/19/2026 Filed 2026-05-19SCHEDULE 13D/AAmendment 3Open filing 0001072613-26-000486 Dispute this row
Forest Baskett Common Stock, $0.0001 par value per share4.93,568,781.0005/19/2026 Filed 2026-05-19SCHEDULE 13D/AAmendment 3Open filing 0001072613-26-000486 Dispute this row
Anthony A. Florence, Jr. Common Stock, $0.0001 par value per share4.93,568,781.0005/19/2026 Filed 2026-05-19SCHEDULE 13D/AAmendment 3Open filing 0001072613-26-000486 Dispute this row
Mohamad H. Makhzoumi Common Stock, $0.0001 par value per share4.93,568,781.0005/19/2026 Filed 2026-05-19SCHEDULE 13D/AAmendment 3Open filing 0001072613-26-000486 Dispute this row
Scott D. Sandell Common Stock, $0.0001 par value per share4.93,568,781.0005/19/2026 Filed 2026-05-19SCHEDULE 13D/AAmendment 3Open filing 0001072613-26-000486 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.0001 per share2.11,480,823.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-002022 Dispute this row
KEVIN TANG Common Stock, par value $0.0001 per share2.11,480,823.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-002022 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.0001 per share0.8529,097.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-002022 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.0001 per share1.3951,726.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-002022 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.0001 per share0.00.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-002022 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.0001 per share0.00.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 2Open filing 0001214659-26-002022 Dispute this row
Samsara BioCapital, L.P. Common Stock, $0.0001 par value per share4.93,507,666.0011/20/2025 Filed 2025-11-24SCHEDULE 13D/AAmendment 3Open filing 0001699737-25-000025 Dispute this row
Samsara BioCapital GP, LLC Common Stock, $0.0001 par value per share4.93,507,666.0011/20/2025 Filed 2025-11-24SCHEDULE 13D/AAmendment 3Open filing 0001699737-25-000025 Dispute this row
Srinivas Akkaraju Common Stock, $0.0001 par value per share4.93,507,666.0011/20/2025 Filed 2025-11-24SCHEDULE 13D/AAmendment 3Open filing 0001699737-25-000025 Dispute this row
Citadel Advisors LLC Common Stock, par value $0.0001 per share (the "Shares")3.42,444,273.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112481 Dispute this row
Citadel Advisors Holdings LP Common Stock, par value $0.0001 per share (the "Shares")3.42,444,273.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112481 Dispute this row
Citadel GP LLC Common Stock, par value $0.0001 per share (the "Shares")3.42,444,273.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112481 Dispute this row
Citadel Securities LLC Common Stock, par value $0.0001 per share (the "Shares")0.6456,085.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112481 Dispute this row
Citadel Securities Group LP Common Stock, par value $0.0001 per share (the "Shares")0.6456,085.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112481 Dispute this row
Citadel Securities GP LLC Common Stock, par value $0.0001 per share (the "Shares")0.6456,085.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112481 Dispute this row
Kenneth Griffin Common Stock, par value $0.0001 per share (the "Shares")4.12,900,358.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 1Open filing 0001104659-25-112481 Dispute this row
BlackRock, Inc. Common Stock4.963,524,32209/30/2025 Filed 2025-10-17SCHEDULE 13G/AAmendment 1Open filing 0002012383-25-002680 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,578,969 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020205,260
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026262,405

Filings made before the SEC required XML are listed, not extracted.

Back to Nkarta, Inc.